Psychedelic-Assisted therapy offers new hope for PTSD sufferers
NCT ID NCT05746572
Summary
This study is testing whether a single dose of MDMA, combined with an intensive two-week therapy program, can help reduce PTSD symptoms. All 40 participants will receive the MDMA-assisted therapy during the treatment. Researchers want to see if adding MDMA makes the established therapy more effective for people struggling with PTSD.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PTSD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory Brain Health Center
Atlanta, Georgia, 30329, United States
Conditions
Explore the condition pages connected to this study.